NCT02795988 2025-04-16
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Imugene Limited
Phase 1/2 Completed
Imugene Limited
Nektar Therapeutics
Altor BioScience
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Merck KGaA, Darmstadt, Germany
Amgen